Patients’ adherence to anti-tuberculosis medicines and associated factors for non-adherence at a tertiary teaching hospital, South West Ethiopia
DOI:
https://doi.org/10.5578/gmj.32149Keywords:
Adherence, tuberculosis, treatment failure, directly observed therapy, Jimma University Specialized HospitalAbstract
Introduction: Tuberculosis is the global problem, which may infect one third of the world population annually. A major contributor for the re-emergence of TB is lack of adherence to anti-TB drugs. Non-adherence to anti-TB treatment is the persistent problem throughout the world, including the developing and developed countries. The main objective of this study was to determine the rate of non-adherence to anti-TB treatment and associated factors for non-adherence among TB patients in Jimma University Specialized Hospital.
Materials and Methods: Prospective cross sectional study was conducted in TB clinic of Jimma University Specialized Hospital using pretested structured questionnaire from February 10, 2013, to February 20, 2013
Results: From a total of 67 patients interviewed during the study period, majority of them (83.58%) were between 18-40 years. About 88% of patients were adherent to their medication and the rest missed doses at least once during the course of their treatment. The main reasons for non-adherence were lack of family support (37.50%) and far distance from hospital (25%). Less education and HIV positive have association with non-adherence (p< 0.001).
Conclusion: Generally the adherence to anti-TB treatment among TB patients in Jimma University Specialized Hospital was good, even though some patients were missing their treatments.
References
WHO. Global report on tuberculosis, Geneva, Switzerland. 2012;8-25.
MOH. National tuberculosis, Leprosy TB/HIV Control programme Manual, 4th ed. Ethiopia: Addis Ababa, 2008;2-4.
Health module, communicable disease, Tuberculosis burden in Ethiopia, 2010.
WHO regional office for Europe, The Global Plan to Stop TB, Copenhagen, Denmark, EUR/TB/FS013 September 2007:1-2.
Boogaard JV. Non-adherence to tuberculosis treatment: An integral approach to measure and prevent it. Radboud University, Nijmegen, 2011;275.
van den Boogaard J, Lyimo RA, Boeree MJ, Kibiki GS, Aarnoutse RE. Electronic monitoring of treatment adherence and validation of alternative adherence measures in tuberculosis patients: a pilot study. Bull World Health Organ 2011;89(9):632-9.
Zeleke. Ethiopian national TB prevalence surveys preliminary result; Lille, France 2010-2011.
Balchi S, Anbe W, Sathiakumar N. Determinant of poor adherence to anti-tuberculosis treatment in Mumbai, India. Int J Prev Med 2010;1(4):223-32.
Castlenuovo B. A review of compliance to Anti- tuberculosis treatment and risk factors for defaulting treatment in Sub Saharan Africa. Afr Health Sci 2010;10(4):320-4.
Ansari Md, Khayyam KU, Sharma M, et al. The role of socioeconomic factors responsible for non-compliance of DOTS among tuberculosis patients, New Delhi, India. Journal of Medicine and Health Sciences 2011;18:2-9.
Chani K. Factors affecting compliance to tuberculosis treatment in Andarakavango region, Namibia. Int J Prev Med 2010;1(4):223-32.
Culqui DR, Munayco E CV, Grijalva CG, Cayla JA, Horna-Campos O, Alva Ch K, et al. Factors associated with the non-completion of conventional anti-TB treatment, Peru. Arch Bronconeumol 2010;48(5):150-5.
Gelmanova IY, Keshavjee S, Golubchikova VT, Berezina VI, Strelis AK, Yanova GV, et al. Barriers to successful tuberculosis treatment in Tomsk, Russian Federation: non-adherence, default and the acquisition of multidrug resistance. Bull World Health Organ 2007;85(9):703-11.
Khan A, Usmani A, Sultana A. Risk factors in development of MDRTB in the hospitalized patients, Pakistan. Journal of Army Crops 2005;4:30-9648.
Starr B, Sacks R. Improving outcomes for patients with chronic disease: medication adherence project, New York City, 2010;8.
Balbay O, Annakkaya AN, Arbak P, Bilgin C, Erbas M. Which patients are able to adhere to tuberculosis treatment? A study in a rural area in the northwest part of Turkey. Jpn J Infect Dis 2005 Jun;58(3):152-8.
Yone EWP, Kengne AP, Kuaban C. Incidence, time and determinants of tuberculosis treatment default in Yaoundé, Cameroon. BMJ Open 2011;1:e000289 doi: 10.1136/bmjopen-2011-000289.
Amuha MG, Kutyabami P, Kitutu FE, Odoi-Adome R, Kalyango JN. Non-adherence to anti-TB drugs among TB/HIV co-infected patients in Mbarara Hospital Uganda: prevalence and associated factors. Afr Health Sci 2009;(9 Suppl 1):S8-S15.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 European Journal of Therapeutics
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The content of this journal is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
